India reported a slight decline in new Covid-19 cases, with the country reporting 2,35,532 infections. 

As many as 871 deaths have been reported in the past 24 hours, says Saturday morning’s Union Health Ministry update, which is considerably more than the 627 deaths that were recorded on Friday. 

The daily positivity rate has reduced to 13.39% as well. The current number of active cases is 20,04,333, while 3,35,939 have recovered from the virus.

Meanwhile, the health woes of the patients infected with Covid-19 in the second wave still continues as many are being diagnosed with the long post-Covid complications of Avascular Necrosis (AVN), referred to as bone death. 

To find a clinical explanation, All India Institute of Medical Sciences (AIIMS) has submitted a proposal to the Indian Council of Medical Research (ICMR) seeking approval for a multicentric study to probe cases of AVN among Covid-19 recovered patients.

Bharat Biotech, the maker of Covaxin, on Friday obtained approval from the Drugs Controller General of India (DCGI) for conducting trials of its intranasal booster doses against Covid-19 (BBV154). 

According to news agency ANI, the trials will be conducted at nine different sites in India.

Source: NDTV

BDST: 1250 HRS, JAN 29, 2022
SMS